FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

40561011000001104: MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Apr 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2211581000001119 MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2211591000001117 MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) Is a Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules true Inferred relationship Existential restriction modifier
MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) Is a MagnaPhos true Inferred relationship Existential restriction modifier
MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) Has specific active ingredient Magnesium glycerophosphate true Inferred relationship Existential restriction modifier
MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) 50 capsule Has AMP True MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start